AMC Robotics (AMCI) Shares Slide -63% in 30 Days on Equity Line Concerns

Key Takeaways

• AMC Robotics (AMCI) shares fell roughly 63% over the last 30 days, sliding from a closing price near $2.59 on October 13, 2026, to approximately $0.97.
• The decline accelerated after the SEC declared the company's resale registration statement effective in early November, activating a $50 million equity line and creating significant share-supply and dilution pressure.
• The stock is down about 79% over the past quarter, extending a multi-month downtrend that began after a sharp August 2026 peak.
• Second-quarter 2026 revenue declined 33% year over year to roughly $937,000, even as gross margin improved to 80% and the net loss narrowed to about $176,000.
• AMCI remains a micro-cap, largely pre-commercialization robotics company with meaningful customer concentration risk, including a related-party relationship that accounted for about 52% of 2025 revenue.
• For additional detail, investors can explore Price Targets, Earnings, and Forecast pages for this ticker.
• Readers can also explore Trending AI Robots for AI-driven trading signals and strategies.

Company Background and Market Position

AMC Robotics Corporation is a New York-based, AI-driven robotics and smart security company that began trading on Nasdaq under the ticker AMCI in December 2025 after completing a business combination with AlphaVest Acquisition Corp. The company develops intelligent hardware and software, including its Kyro quadruped robotic platform for inspection, security, and operational automation, and NovaArm, a warehouse logistics robot aimed at sorting and distribution-center tasks. It also sells residential and small-business smart camera and security devices under the "YI" brand, primarily through e-commerce channels in North America and Europe.

As an early-stage, micro-cap company competing against larger automation and security providers such as Symbotic (SYM), Zebra Technologies (ZBRA), and established industrial robotics makers, AMC Robotics is closely watched for its progress toward commercializing NovaArm and scaling its Kyro platform rather than for near-term profitability. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Stock Price Performance: Last 30 Days vs. Quarter

Over the last 30 days, AMCI shares fell approximately 63%, declining from a close of about $2.59 on October 13, 2026, to roughly $0.97. The sell-off was not uniform: the stock held near the low $2 range through late October before collapsing in early November as a resale registration statement became effective.

The quarterly picture is even more pronounced. From a mid-August 2026 close near $4.61, the stock has dropped roughly 79%. This followed a volatile late-summer stretch in which AMCI briefly spiked above $6 intraday before reversing sharply, and the trend has remained decisively lower into November.

What Drove the Recent 30-Day Move

The primary catalyst was financing-related dilution risk. On September 18, 2026, the company announced a $50 million standby equity purchase agreement with an institutional investor plus an initial $3.88 million in convertible promissory notes, with proceeds earmarked for its robotic manufacturing facility. Because the convertible notes carry a floating conversion price tied to the lowest recent volume-weighted average price, falling share prices would translate into more shares issued.

Pressure intensified after the company filed a registration statement on October 22, 2026, and the SEC declared the related prospectus effective in early November. That action enabled resale of a large block of shares and activated the equity line, prompting investors to price in meaningful share overhang. The stock fell about 16% in a single session in early November and continued lower in subsequent days, with trading volume surging well above prior levels.

Sentiment was also weighed down by fundamental concerns, including a second-quarter revenue decline of 33% year over year, ongoing operating losses, and disclosure of material weaknesses in internal controls over financial reporting.

Quarterly Performance Drivers

Over the past quarter, the dominant narrative has been a steady deflation of a speculative premium. After a sharp August spike, the stock entered a prolonged downtrend as investors reassessed a company with a market capitalization measured in the tens of millions of dollars, limited commercial revenue, and a customer base concentrated around a related party, Kami Vision Incorporated, which contributed roughly 52% of fiscal 2025 revenue.

Layered on top were recurring governance and reporting issues, including a delayed annual report filing related to warrant accounting and unresolved material weaknesses. The September equity-line and convertible-note agreement, followed by the registration becoming effective in November, reinforced a supply-side overhang that has kept selling pressure elevated throughout the quarter.

What to Watch Next for AMCI

Several factors are likely to shape AMCI's near-term trajectory. First, investors will monitor whether the company draws on its $50 million equity line and how any share issuances or convertible-note conversions affect the outstanding share count. Second, progress on the NovaArm manufacturing facility and the timing of its commercial launch, along with any first named deployment customer, will be key operational milestones.

Third, upcoming quarterly results will be scrutinized for revenue trends, gross-margin durability, and cash position, given a cash balance of about $4.5 million as of June 30, 2026. Finally, governance matters such as remediation of disclosed material weaknesses and any exchange-listing compliance issues remain important risks. These factors carry execution and financing uncertainty, and readers should evaluate them in the context of their own research and risk tolerance. From what I see, I’m watching this closely.

AI Tools in My Research Process

In my research, I often turn to Tickeron’s AI Trading Bots to review automated signals across volatile names. The platform draws from hundreds of bots trading thousands of tickers and highlights top-performing strategies spanning different timeframes and asset classes. Each bot generates signals based on quantitative analysis, offering a practical way to monitor conditions without replacing my own due diligence. This approach has helped me cross-check sentiment and potential entry points on names like AMCI.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Notable companies

Industry description

Market Cap

High and low price notable news

Volume